PDS Biotechnology (STU:EU6) Ending Cash Position : €44.83 Mil (As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is PDS Biotechnology Ending Cash Position?

PDS Biotechnology's Ending Cash Position for the quarter that ended in Sep. 2024 was €44.83 Mil.

PDS Biotechnology's quarterly Ending Cash Position declined from Mar. 2024 (€61.30 Mil) to Jun. 2024 (€53.64 Mil) and declined from Jun. 2024 (€53.64 Mil) to Sep. 2024 (€44.83 Mil).

PDS Biotechnology's annual Ending Cash Position increased from Dec. 2021 (€57.74 Mil) to Dec. 2022 (€69.69 Mil) but then declined from Dec. 2022 (€69.69 Mil) to Dec. 2023 (€51.87 Mil).

PDS Biotechnology Ending Cash Position Historical Data

The historical data trend for PDS Biotechnology's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PDS Biotechnology Ending Cash Position Chart

PDS Biotechnology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

10.95

23.71

57.74

69.69

51.87

PDS Biotechnology Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Ending Cash Position	Get a 7-Day Free Trial															50.83	51.87	61.30	53.64	44.83

PDS Biotechnology Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

PDS Biotechnology's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	67.693	+	-15.827
	=	51.87

PDS Biotechnology's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	52.019	+	-7.193
	=	44.83

PDS Biotechnology Ending Cash Position Related Terms

Thank you for viewing the detailed overview of PDS Biotechnology's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

PDS Biotechnology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PDS Biotechnology Corp (STU:EU6) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

PDSB:USA EU6:Germany

Address

303A College Road, East Princeton, NJ, USA, 08540

Website

https://www.pdsbiotech.com

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

PDS Biotechnology Headlines

No Headlines